close
To:

From:

KYNAMRO™ Data Presented at ESC

Isis Pharmaceuticals hosts Dr. Klaus Parhofer to review KYNAMRO™ data presented at the European Society of Cardiology Congress 2012.

Click here to access a replay of the Webcast that was held on
Wednesday, August 29 at 10:00 a.m. ET

Click here to download the slides »

Antisense

Antisense technology is opening new doors in the way we treat disease.

Learn More

Pipeline

Our pipeline continues to grow with novel therapies in development to treat patients who have significant unmet medical needs.

Learn More